Renal glucose innovation creating infrastructure — SGLT2 inhibitors providing urinary glucose excretion managing type 2 diabetes enabling metabolic control, establishing SGLT2 inhibitors as essential diabetes infrastructure, with the Sodium Glucose Cotransporter 2 Inhibitor Market experiencing expansion driven by diabetes prevalence, glycemic control emphasis, and SGLT2 advancement...